Where does Amano Enzyme U.S.A. Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Amano Enzyme U.S.A. Co., Ltd. ranks #44,651 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Amano Enzyme U.S.A. Co., Ltd. hold?

Amano Enzyme U.S.A. Co., Ltd. holds 5 US utility patents granted between 2015 and 2017, spanning 8 technology areas.

What is Amano Enzyme U.S.A. Co., Ltd.'s Innovation Score?

Amano Enzyme U.S.A. Co., Ltd. has an Innovation Score of 22.3 out of 100 (10th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Amano Enzyme U.S.A. Co., Ltd. focus on?

Amano Enzyme U.S.A. Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 4 patents, ranking #4,040 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Amano Enzyme U.S.A. Co., Ltd.'s patent grant rate increasing or decreasing?

Amano Enzyme U.S.A. Co., Ltd.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Amano Enzyme U.S.A. Co., Ltd.'s patents?

Amano Enzyme U.S.A. Co., Ltd.'s patents average 10.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Amano Enzyme U.S.A. Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Amano Enzyme U.S.A. Co., Ltd.

USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Amano ranks #44,651 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 8 technology areas.

#44,651
of 49,997 US assignees by volume: 10th percentile
by Innovation Score (22.3/100): 10.2
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44651 · US Corporation #44,651 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
LOWER-Q #44,651/49,997
PHOTO-FINISH AM-Pharma B V
CPC-NARROW A61P · 8 areas
INNOV-THIN 22.3/100
CLAIMS-PAR 10.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AM-Pharma B.V. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Amano’s 22.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (28%) Velocity 0.0 pts (0%) Breadth 10.0 pts (45%) Claim depth 6.1 pts (27%)

Qualcomm Incorporated · highest

85
Anitox · near

22
Amano Enzyme U · this assignee

22
Tanvas · near

22
Genisphere · near

22
Newtec CY · near

22
3D Lighting… · lowest

7

What this shows Amano's Innovation Score is 22.3/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Amano?

Each dot is one of Amano’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Amano’s own 10.2 claims/patent is at or below the 13.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Amano vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Amano's grants concentrate

Amano Enzyme U.S.A. Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 80% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2016. By volume, Amano sits between AM Technology Co., Ltd. and Amcor Flexibles Singen GMBH.

AM Technology

5
Am-pharma B V

5
Amag Pharmaceutic…

5
Amag Rolling

5
Amatrimara

5
Amberstone Biosci…

5
Ambient Photonics

5
Amcor Flexibles S…

5
Amano Enzyme U ◀

5

What this shows Amano holds 5 patents at rank #44,515, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Amano

By rank, the assignees closest to #44,515 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Amano's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Amano, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Amano ranks #4,040 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (22 here).

Anitox Corporation 22 Tanvas, Inc. 22 Newtec CY 22 Genisphere, LLC 22

Amano's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

22 10th percentile higher than 10% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Amano Enzyme U.S.A. Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	60.0%
2016	1	20.0%
2017	1	20.0%

Which technologies does Amano Enzyme U.S.A. Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C12Y - Enzymes 3

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

C08B - POLYSACCHARIDES; Derivatives Thereof 2

C08L - Compositions OF Macromolecular Compounds 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

A23C - Dairy Products, e.g. Milk, Butter OR CHEESE; Milk OR Cheese SUBSTITUTES; Making OR Treatment Thereof 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Amano Enzyme U.S.A. Co., Ltd.'s patent record in context - here's where to go next.

Amano Enzyme U.S.A. Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 80% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #44,651 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Amano Enzyme U.S.A. Co., Ltd. against AM Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 22.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.